Friday’s STI pullback looked like “red across the board”, but the real story was much narrower, UOB taking a bigger hit than DBS and OCBC after a Citi analyst questioned whether its asset quality turnaround has been quietly over‑priced into expectations. At the same time, Hin Leong’s US$2.6 billion claim against Deloitte was struck out by Singapore’s Court of Appeal, a reminder that clean audits do not shield you from management’s trading decisions. In this episode, Angela and I walk through how those two headlines connect for a CPF and SRS investor who thinks of banks as safe and audits as comfort. The goal is not to scare you, it is to show you where the real boundary lines are so you stop outsourcing risk management to labels that do less work than you think.
Key takeaways:
UOB fell about 2.4%, while DBS and OCBC slipped less than 1%, showing name specific risk.
A Citi analyst warned UOB’s upcoming earnings could miss once one off income is stripped out.
The latest 6 month T‑bill auction cleared at 1.50%, up from 1.47%, contradicting the “rates must fall soon” story.
Hin Leong’s US$2.6 billion trading loss claim against Deloitte was struck out, leaving only US$90 million dividends and S$612,000 fees on the table.
The Court of Appeal explicitly ruled those trading losses “too remote”, limiting how far audit liability stretches for investors.
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
